Cargando…

Gene therapy in rare diseases: the benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID

BACKGROUND: Strimvelis (autologous CD34+ cells transduced to express adenosine deaminase [ADA]) is the first ex vivo stem cell gene therapy approved by the European Medicines Agency (EMA), indicated as a single treatment for patients with ADA-severe combined immunodeficiency (ADA-SCID) who lack a su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stirnadel-Farrant, Heide, Kudari, Mahesh, Garman, Nadia, Imrie, Jessica, Chopra, Bikramjit, Giannelli, Stefania, Gabaldo, Michela, Corti, Ambra, Zancan, Stefano, Aiuti, Alessandro, Cicalese, Maria Pia, Batta, Rohit, Appleby, Jonathan, Davinelli, Mario, Ng, Pauline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889583/ https://www.ncbi.nlm.nih.gov/pubmed/29625577 http://dx.doi.org/10.1186/s13023-018-0791-9

Ejemplares similares

Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis
por: Tucci, Francesca, et al.
Publicado: (2018)

Hemophagocytic inflammatory syndrome in ADA-SCID: report of two cases and literature review
por: Fratini, Elena Sophia, et al.
Publicado: (2023)

Outcome of BCG Vaccination in ADA-SCID Patients: A 12-Patient Series
por: Canarutto, Daniele, et al.
Publicado: (2023)

Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis- related graft failure and disseminated bacillus Calmette-Guérin infection
por: Tucci, Francesca, et al.
Publicado: (2020)

Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products
por: Aiuti, Alessandro, et al.
Publicado: (2017)

Maternal T-cell engraftment impedes with diagnosis of a SCID-ADA patient
por: Lanfranchi, Arnalda, et al.
Publicado: (2018)

Evaluation of clonal hematopoiesis in pediatric ADA-SCID gene therapy participants
por: White, Shanna L., et al.
Publicado: (2022)

Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clones
por: Uchiyama, Toru, et al.
Publicado: (2021)

Review of Treatment for Adenosine Deaminase Deficiency (ADA) Severe Combined Immunodeficiency (SCID)
por: Secord, Elizabeth, et al.
Publicado: (2022)

Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID)
por: Booth, Claire, et al.
Publicado: (2009)

Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy
por: Moretti, Federico A., et al.
Publicado: (2021)

PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID
por: Dorsey, Morna J., et al.
Publicado: (2023)

Correction to: PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID
por: Dorsey, Morna J., et al.
Publicado: (2023)

The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy
por: Naldini, Luigi, et al.
Publicado: (2022)

Patient‐driven search for rare disease therapies: the Fondazione Telethon success story and the strategy leading to Strimvelis
por: Monaco, Lucia, et al.
Publicado: (2017)

Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy
por: Igarashi, Yuka, et al.
Publicado: (2017)

Author Correction: Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy
por: Moretti, Federico A., et al.
Publicado: (2021)

ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation
por: Barzaghi, Federica, et al.
Publicado: (2019)

Changing use of antidiabetic drugs in the UK: trends in prescribing 2000–2017
por: Wilkinson, Samantha, et al.
Publicado: (2018)

Gene delivery using AAV8 in vivo for disease stabilization in a bimodal gene therapy approach for the treatment of ADA-deficient SCID
por: Carbonaro-Sarracino, Denise A., et al.
Publicado: (2021)

A systematic review comparing the evidence for kidney function outcomes between oral antidiabetic drugs for type 2 diabetes
por: Wilkinson, Samantha V., et al.
Publicado: (2018)

Strimvelis(®) for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation
por: South, Emily, et al.
Publicado: (2018)

Anemia and mortality in patients with nondialysis-dependent chronic kidney disease
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2018)

Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2023)

Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2023)

Ada Lovelace
por: Jeapes, Ben, et al.
Publicado: (2019)

Ada Lovelace
por: Jeapes, Ben, et al.
Publicado: (2020)

Comparative effects of sulphonylureas, dipeptidyl peptidase‐4 inhibitors and sodium‐glucose co‐transporter‐2 inhibitors added to metformin monotherapy: a propensity‐score matched cohort study in UK primary care
por: Wilkinson, Samantha, et al.
Publicado: (2020)

Characteristics, treatment patterns, health care resource utilization and costs in patients with bullous pemphigoid: A retrospective analysis of US health insurance claims data
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2023)

Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary care
por: Wilkinson, Samantha, et al.
Publicado: (2018)

Ada-WHIPS: explaining AdaBoost classification with applications in the health sciences
por: Hatwell, Julian, et al.
Publicado: (2020)

Atypical Hemolytic Uremic Syndrome (aHUS) and Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID)—Two Diseases That Exacerbate Each Other: Case Report
por: Bogdał, Anna, et al.
Publicado: (2021)

Genetics of SCID
por: Cossu, Fausto
Publicado: (2010)

Rendezvous with Ada 95
por: Naiditch, David, et al.
Publicado: (1995)

Software engineering with Ada
por: Booch, Grady, et al.
Publicado: (1994)

Ada for software engineers
por: Ben-Ari, M
Publicado: (1998)

Software engineering with ADA
por: Booch, Grady
Publicado: (1983)

Software engineering with Ada
por: Booch, Grady
Publicado: (1987)

Ada International Conference
por: Barnes, John Gilbert Presslie, et al.
Publicado: (1985)

Cardiovascular Event Rates Among Hemodialysis Patients Across Geographical Regions—A Snapshot From The Dialysis Outcomes and Practice Patterns Study (DOPPS)
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e24tfoo5bgvv537uqhb7daecvu